| HOME >> MEDICINE >> TECHNOLOGY |
men of normal weight at the time of diagnosis. "If a man is obese
at the time of diagnosis, he faces a 2.6-times greater risk of dying as
compared to a normal-weight man with the same diagnostic profile,
regardless of whether he has a radical prostatectomy or radiation
therapy, whether or not he gets androgen-deprivation therapy, whether he
has low- or high-grade disease or whether he has localized, regional or
distant disease," Kristal said.
-- Heavy smokers who are diagnosed with prostate cancer have twice the risk
of dying from their disease. Smoking may promote prostate cancer growth
through several mechanisms. One is that it can increase the amount of
circulating androgens, which fuels the growth of malignant prostate
cells. Another theory is related to tobacco as a source of cadmium, a
heavy metal that has been linked to prostate cancer in several
occupational-health studies. This known human carcinogen inhibits DNA
repair, which allows cancer cells to mutate and multiply.
-- African-American men are known to have a higher risk of prostate cancer
than white men. Kristal and colleagues also found that African-American
men have a 50 percent higher risk of developing symptomatic BPH than
white men.
-- The excitement about lycopene (the pigment that puts the red in
tomatoes) and prostate-cancer prevention is probably a mistake, Kristal
says. Most large and well-designed human studies, and most animal
studies, have failed to find convincing associations between lycopene
and reduced prostate-cancer risk. Men should be wary of quick fixes like
lycopene supplements, vegetable-juice powders or other agents promoted
for prostate-cancer prevention.
The take-away messag
'/>"/>
| SOURCE Fred Hutchinson Cancer Research Center Copyright©2008 PR Newswire. All rights reserved |